Literature DB >> 25113583

Effect of genetic and pharmacological blockade of GABA receptors on the 5-HT2C receptor function during stress.

Cédric B P Martin1, Martin Gassmann, Caroline Chevarin, Michel Hamon, Uwe Rudolph, Bernhard Bettler, Laurence Lanfumey, Raymond Mongeau.   

Abstract

Serotonin (5-HT)2C receptors play a role in psychoaffective disorders and often contribute to the antidepressant and anxiolytic effects of psychotropic drugs. During stress, activation of these receptors exerts a negative feedback on 5-HT release, probably by increasing the activity of GABAergic interneurons. However, to date, the GABA receptor types that mediate the 5-HT2C receptor-induced feedback inhibition are still unknown. To address this question, we assessed the inhibition of 5-HT turnover by a 5-HT2C receptor agonist (RO 60-0175) at the hippocampal level and under conditions of stress, after pharmacological or genetic inactivation of either GABA-A or GABA-B receptors in mice. Neither the GABA-B receptor antagonist phaclofen nor the specific genetic ablation of either GABA-B1a or GABA-B1b subunits altered the inhibitory effect of RO 60-0175, although 5-HT turnover was markedly decreased in GABA-B1a knock-out mice in both basal and stress conditions. In contrast, the 5-HT2C receptor-mediated inhibition of 5-HT turnover was reduced by the GABA-A receptor antagonist bicuculline. However, a significant effect of 5-HT2C receptor activation persisted in mutant mice deficient in the α3 subunit of GABA-A receptors. It can be inferred that non-α3 subunit-containing GABA-A receptors, but not GABA-B receptors, mediate the 5-HT2C -induced inhibition of stress-induced increase in hippocampal 5-HT turnover in mice.
© 2014 International Society for Neurochemistry.

Entities:  

Keywords:  GABA-A α3 subunit; GABA-B; bicuculline; knockout; phaclofen

Mesh:

Substances:

Year:  2014        PMID: 25113583      PMCID: PMC4237664          DOI: 10.1111/jnc.12929

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  31 in total

1.  Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies.

Authors:  Thomas I F H Cremers; Kieran Rea; Fokko J Bosker; Håkan V Wikström; Sandra Hogg; Arne Mørk; Ben H C Westerink
Journal:  Neuropsychopharmacology       Date:  2007-01-03       Impact factor: 7.853

2.  GABAergic antagonist blocks the reduction of tonic immobility behavior induced by activation of 5-HT2 receptors in the basolateral nucleus of the amygdala in guinea pigs.

Authors:  Alberto Ferreira Donatti; Christie Ramos Andrade Leite-Panissi
Journal:  Brain Res Bull       Date:  2009-05-05       Impact factor: 4.077

3.  In vivo evidence that 5-HT(2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanism.

Authors:  L Boothman; J Raley; F Denk; E Hirani; T Sharp
Journal:  Br J Pharmacol       Date:  2006-10-16       Impact factor: 8.739

4.  Strain-dependent serotonin neuron feedback control: role of serotonin 2C receptors.

Authors:  Eleonora Calcagno; Roberto W Invernizzi
Journal:  J Neurochem       Date:  2010-08-19       Impact factor: 5.372

5.  Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat.

Authors:  Xavier López-Gil; Zoila Babot; Mercè Amargós-Bosch; Cristina Suñol; Francesc Artigas; Albert Adell
Journal:  Neuropsychopharmacology       Date:  2007-03-14       Impact factor: 7.853

6.  Selective activation of 5-HT(2C) receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study.

Authors:  R W Invernizzi; M Pierucci; E Calcagno; G Di Giovanni; V Di Matteo; A Benigno; E Esposito
Journal:  Neuroscience       Date:  2006-12-08       Impact factor: 3.590

7.  Further pharmacological characterization of 5-HT(2C) receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo.

Authors:  P Quérée; S Peters; T Sharp
Journal:  Br J Pharmacol       Date:  2009-10-20       Impact factor: 8.739

8.  Restraint stress increases serotonin release in the central nucleus of the amygdala via activation of corticotropin-releasing factor receptors.

Authors:  Bing Mo; Na Feng; Kenneth Renner; Gina Forster
Journal:  Brain Res Bull       Date:  2008-03-04       Impact factor: 4.077

9.  Serotonin2C receptor localization in GABA neurons of the rat medial prefrontal cortex: implications for understanding the neurobiology of addiction.

Authors:  S Liu; M J Bubar; M F Lanfranco; G R Hillman; K A Cunningham
Journal:  Neuroscience       Date:  2007-04-30       Impact factor: 3.590

10.  Serotonin activates the hypothalamic-pituitary-adrenal axis via serotonin 2C receptor stimulation.

Authors:  Lora K Heisler; Nina Pronchuk; Katsunori Nonogaki; Ligang Zhou; Jacob Raber; Loraine Tung; Giles S H Yeo; Stephen O'Rahilly; William F Colmers; Joel K Elmquist; Laurence H Tecott
Journal:  J Neurosci       Date:  2007-06-27       Impact factor: 6.167

View more
  3 in total

1.  Constitutive activity of 5-HT2C receptors is present after incomplete spinal cord injury but is not modified after chronic SSRI or baclofen treatment.

Authors:  V M Tysseling; D A Klein; R Imhoff-Manuel; M Manuel; C J Heckman; M C Tresch
Journal:  J Neurophysiol       Date:  2017-09-06       Impact factor: 2.714

2.  Effects of GABAa receptor antagonists on motor behavior in pharmacological Parkinson's disease model in mice.

Authors:  Karla De Michelis Mograbi; Ana Carolini Ferreira de Castro; Jainny Aniely Rocha de Oliveira; Patrick Jean Barbosa Sales; Luciene Covolan; Eliane Aparecida Del Bel; Albert Schiaveto de Souza
Journal:  Physiol Rep       Date:  2017-03

Review 3.  Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action.

Authors:  Mark J Millan
Journal:  Ther Adv Psychopharmacol       Date:  2022-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.